-38%

est. 2Y upside i

HealthcareSeries D+

Direct-to-patient healthcare platform for telehealth and pharmacy services

Rank

#3135

Sector

Healthcare

Est. Liquidity

~3Y

Data Quality

Data: Low

Ro's equity carries significant downside risk over a 2-year horizon due to a stale $7B valuation and likely multiple compression toward public comps.

Last updated: July 21, 2026

Bull (20%)+20%

If Ro capitalizes on the GLP-1 boom and IPOs within 2 years, the valuation multiple could hold at 8x on $1.23B projected revenue, implying a $9.8B exit. After 20% dilution from a capital raise, net upside is approximately 20%.

Base (35%)-32%

Multiple compresses to 5x as growth decelerates, yielding a $6.13B exit value. With 20% dilution from a likely capital raise, net downside is -32.4%.

Bear (45%)-67%

Intense competition from incumbents like Hims & Hers and regulatory hurdles compress the multiple to 3x, implying a $3.68B exit. After 20% dilution, common stock returns -67.4%.

Est. time to liquidity~3.0 years
Adjusted for competitive dynamics: -41% (raw: -38%, adjustment: -3%)

Preference Stack Risk

moderate

Funding Intensity

15%

Total funding $1.03B vs valuation $7B = 14.7%, moderate preference overhang.

Dilution Risk

high

Given 4 years since last round, a down round or massive dilution is likely.

Secondary Liquidity

none

No secondary market known.

Operations 3 roles

Cyber 2 roles

Legal 2 roles

People 2 roles

Providers 2 roles

[General] Keep In Touch 1 role

Clinical 1 role

Growth 1 role

Product 1 role

View all 36 open roles at Ro

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Ro's data — designed to show you've done your homework.

  • 1

    How does Ro plan to differentiate from Hims & Hers in a consolidating market?

  • 2

    What is Ro's path to profitability and timing for cash flow break-even?

  • 3

    How does the equity grant's liquidity horizon align with your career timeline?

Community

Valuation Sentiment

Our model estimates -38% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.